From Harvard: Conflicts of interest, institutional corruption, and pharma: an agenda for reform

http://www.ncbi.nlm.nih.gov/pubmed/23061578

J Law Med Ethics. 2012 Sep;40(3):511-22. doi: 10.1111/j.1748-720X.2012.00683.x.

Conflicts of interest, institutional corruption, and pharma: an agenda for reform.

Rodwin MA.

Source

Professor of Law at Suffolk University Law School and a Lab Fellow at the Edmond J. Safra Center for Ethics at Harvard University.

Abstract

When physicians' conflicts of interest arise from ties with drug firms, we should shift our focus to the pharmaceutical industry and improper dependencies that cause institutional corruption. This article analyzes eight forms of improper dependencies on pharma and proposes reforms.